奥沙利铂联合氟尿嘧啶、亚叶酸钙治疗晚期大肠癌的临床观察

Clinical observation of oxaliplatin combination with 5-fluorouracil/folinic acid therapy in advanced colorectal cancer

目的:观察奥沙利铂联合氟尿嘧啶、亚叶酸钙治疗晚期大肠癌(ACRC)的疗效和安全性。方法:收治晚期大肠癌患者31例,采用L-OHP 130 mg/m2静脉滴注4小时第1天;CF 200 mg/m2静脉滴注2小时后5-FU 500mg/m2静脉滴注4小时第1-5天,每三周重复。结果:部分缓解(PR)10例,稳定(SD)7例,进展(PD)9例,总有效率38.5％。毒性反应主要为感觉神经毒性(90.3％),其次为恶心呕吐(58.1％)和腹泻(45.2％)。骨髓抑制毒性小。结论:L-OHP联合5-FU、CF治疗大肠癌疗效肯定,耐受性良好,值得临床进一步应用。

Purpose: To evaluate the effect and safety of combination chemotherapy with oxaliplatin( L-OHP) plus 5-fluorouracil(5-FU)/folinic acid( CF) in advanced colorectal cancer( ACRC). Methods: 31 patients with ACRC entered the study. L-OHP 130 mg/m2 , iv infusion for 4 hours on day 1; CF 200 mg/m2 , iv infusion for 2 hours followed by 5-FU 500mg/ m , iv infusion for 4 hours from day 1 to day 5, repeated every 3 weeks. Results: There were 10 partial responses, 7 stable disease, 9 progressive disease, the response rate being 38. 5% . The main adverse effect was neuro-sensory toxicity which was seen in 90. 3% of the patients. Vomitting and diarrhea was observed in 58. 1% and 45. 2% of the patients respectively. Bone marrow suppression was mild. Conclusions: L-OHP combination with 5-FU/CF yields an encouraging response with acceptable toxicity in our study. Furthermore clinical reseach is worthwhile.